Skip to main content
icon for Flu Hospitalization Rate Week 19, 2026?

Flu Hospitalization Rate Week 19, 2026?

icon for Flu Hospitalization Rate Week 19, 2026?

Flu Hospitalization Rate Week 19, 2026?

mag 22

mag 22

85–90 90.3%

80–85 6.9%

<80 1.7%

95–100 <1%

Polymarket
NUOVO

85–90 90.3%

80–85 6.9%

<80 1.7%

95–100 <1%

Polymarket
NUOVO

<80

$620 Vol.

2%

80–85

$367 Vol.

7%

85–90

$727 Vol.

90%

90–95

$219 Vol.

<1%

95–100

$344 Vol.

1%

100+

$261 Vol.

1%

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Recent CDC FluView data show the 2025-2026 influenza season winding down rapidly, with the cumulative laboratory-confirmed hospitalization rate reaching 85.2 per 100,000 population through week 15 and weekly rates falling to just 0.5 per 100,000. National forecasts from the FluSight ensemble project continued sharp declines in new admissions through late May, adding only modest increments to the season total. This trajectory aligns with the market’s strong 85–90 consensus, reflecting typical post-peak seasonal dynamics and the absence of late-season surges in recent comparable years. An unanticipated resurgence or delayed reporting of cases could still push the final rate above 90, but current surveillance indicators make that outcome unlikely.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volume
$2,539
Data di fine
22 mag 2026
Mercato aperto
May 14, 2026, 7:51 PM ET
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Recent CDC FluView data show the 2025-2026 influenza season winding down rapidly, with the cumulative laboratory-confirmed hospitalization rate reaching 85.2 per 100,000 population through week 15 and weekly rates falling to just 0.5 per 100,000. National forecasts from the FluSight ensemble project continued sharp declines in new admissions through late May, adding only modest increments to the season total. This trajectory aligns with the market’s strong 85–90 consensus, reflecting typical post-peak seasonal dynamics and the absence of late-season surges in recent comparable years. An unanticipated resurgence or delayed reporting of cases could still push the final rate above 90, but current surveillance indicators make that outcome unlikely.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volume
$2,539
Data di fine
22 mag 2026
Mercato aperto
May 14, 2026, 7:51 PM ET
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.

Fai attenzione ai link esterni.

Domande frequenti

"Flu Hospitalization Rate Week 19, 2026?" è un mercato predittivo su Polymarket con 6 possibili esiti dove i trader comprano e vendono azioni in base a ciò che credono accadrà. L'esito attualmente in testa è "85–90" a 90%, seguito da "80–85" a 7%. I prezzi riflettono probabilità aggregate in tempo reale. Ad esempio, un'azione quotata a 90¢ implica che il mercato assegna collettivamente una probabilità di 90% a quell'esito. Queste quote cambiano continuamente man mano che i trader reagiscono a nuovi sviluppi e informazioni. Le azioni nell'esito corretto possono essere riscattate per $1 ciascuna alla risoluzione del mercato.

"Flu Hospitalization Rate Week 19, 2026?" è un mercato appena creato su Polymarket, lanciato il May 15, 2026. Come mercato nuovo, questa è la tua opportunità di essere tra i primi trader a stabilire le quote e i segnali di prezzo iniziali del mercato. Puoi anche aggiungere questa pagina ai preferiti per monitorare il volume e l'attività di trading man mano che il mercato guadagna visibilità.

Per fare trading su "Flu Hospitalization Rate Week 19, 2026?", esplora i 6 esiti disponibili elencati in questa pagina. Ogni esito mostra un prezzo corrente che rappresenta la probabilità implicita del mercato. Per prendere una posizione, seleziona l'esito che ritieni più probabile, scegli "Sì" per fare trading a suo favore o "No" per fare trading contro di esso, inserisci il tuo importo e clicca "Trading". Se il tuo esito scelto è corretto alla risoluzione del mercato, le tue azioni "Sì" pagano $1 ciascuna. Se è errato, pagano $0. Puoi anche vendere le tue azioni in qualsiasi momento prima della risoluzione se vuoi consolidare un profitto o limitare una perdita.

L'attuale favorito per "Flu Hospitalization Rate Week 19, 2026?" è "85–90" a 90%, il che significa che il mercato assegna una probabilità di 90% a quell'esito. L'esito successivo più vicino è "80–85" a 7%. Queste quote si aggiornano in tempo reale man mano che i trader comprano e vendono azioni, quindi riflettono l'ultima visione collettiva di ciò che è più probabile che accada. Controlla frequentemente o aggiungi questa pagina ai preferiti per seguire come cambiano le quote man mano che emergono nuove informazioni.

Le regole di risoluzione per "Flu Hospitalization Rate Week 19, 2026?" definiscono esattamente cosa deve accadere affinché ogni esito venga dichiarato vincitore — comprese le fonti di dati ufficiali utilizzate per determinare il risultato. Puoi consultare i criteri completi di risoluzione nella sezione "Regole" di questa pagina sopra i commenti. Ti consigliamo di leggere attentamente le regole prima di fare trading, poiché specificano le condizioni precise, i casi limite e le fonti che regolano come viene risolto questo mercato.